| 股東 | |||||
|---|---|---|---|---|---|
Psyence Labs Ltd. | 30.05% | 114.62 萬 | -- | +114.62 萬 | 25/02/2026 |
Parallel Advisors, LLC | 3.97% | 15.13 萬 | 1.60% | +12.71 萬 | 31/03/2026 |
Jeffrey Weiner | 1.57% | 5.98 萬 | -- | +5.98 萬 | 25/02/2026 |
KAOS Capital Ltd | 1.32% | 5.02 萬 | 3.60% | +0 | |
Neil MareskyGlobal Head of Clinical Development | <0.01% | 276.00 | 0.02% | +0 | 30/09/2025 |
Jody AufrichtigCo-Founder, Executive Chairman & CEO | <0.01% | 177.00 | 0.01% | +0 | 30/09/2025 |
Warwick Corden-LloydCFO & Director | <0.01% | 91.00 | <0.01% | +0 | 30/09/2025 |
Stonehage Fleming (Uk) Limited | <0.01% | 89.00 | <0.01% | +0 | 31/03/2026 |
Christopher BullFormer Independent Director | <0.01% | 64.00 | <0.01% | +0 | 30/09/2025 |
Marc BalkinIndependent Director | <0.01% | 52.00 | <0.01% | +0 | 30/09/2025 |
Seth FeuersteinFormer Member of Scientific Advisory Board | <0.01% | 19.00 | <0.01% | +0 | 30/09/2025 |
Bank of America Corporation | 0.00% | 0.00 | 0.05% | -535.00 | 31/03/2026 |
UBS Asset Management AG | 0.00% | 0.00 | 0.02% | -161.00 | 31/03/2026 |
Virtu Financial, Inc. | 0.00% | 0.00 | 0.58% | -5,926.00 | 31/03/2026 |
